Case Report: Hyper IgM Syndrome Identified by Whole Genome Sequencing in a Young Syrian Man Presenting With Atypical, Severe and Recurrent Mucosal Leishmaniasis
Open Access
- 11 September 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11
Abstract
A previously healthy 19-year-old Syrian man presented with atypical and severe mucosal leishmaniasis caused by Leishmania tropica. During a 2-year period, he had three severe relapses despite various treatment strategies, including liposomal amphotericin B and Miltefosine. Because of the unusual clinical presentation, potential underlying immunodeficiency was investigated. Normal T and NK cell counts were found. The B cell count was slightly elevated at 0.7 × 109 cells/L (0.09 × 109 to 0.57 × 109 cells/L), but the proportions of memory and isotype switched memory B cells were severely diminished IgG levels were low, at 309 mg/dL (610–1490 mg/dL). The initial IgM and IgA levels were within normal range, but the IgA levels decreased to 57 mg/dL (70–430 mg/dL) during follow up. Common variable immunodeficiency (CVID) was initially suspected, because the immunological results of low IgG and IgA, low switched memory B cells, no profound T cell deficiency found and absence of secondary cause of hypogammaglobulinemia were compatible with this diagnosis (ESID 2019). However, the highly unusual and severe clinical presentation of L. tropica is not suggestive of B-cell deficiency or CVID. Eventually a pathogenic nonsense variant in the CD40 ligand gene [p.(Arg11∗)] was identified by whole genome sequencing, thus enabling the diagnosis of X-linked hyper IgM syndrome. This case illustrates and supports the potential for the use of whole genome sequencing in accurate diagnosis of primary immunodeficiencies.Keywords
Funding Information
- Danmarks Grundforskningsfond
This publication has 33 references indexed in Scilit:
- New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulinClinical and Experimental Immunology, 2013
- Phenotypic Heterogeneity in a Family with a CD40 Ligand Intracellular Domain MutationJournal of Clinical Immunology, 2011
- Update on the hyper immunoglobulin M syndromesBritish Journal of Haematology, 2010
- CD40 and the immune response to parasitic infectionsSeminars in Immunology, 2009
- Cerebral toxoplasmosis in a middle-aged man as first presentation of primary immunodeficiency due to a hypomorphic mutation in the CD40 ligand geneJournal of Clinical Pathology, 2008
- Clinical Follow-Up of 11 Argentinian CD40L-Deficient Patients with 7 Unique Mutations Including the So-Called “Milder” MutantsJournal of Clinical Immunology, 2007
- Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndromeBlood, 2005
- The X-Linked Hyper-IgM SyndromeMedicine, 2003
- Visceral Leishmaniasis in a Patient with Hyper-IgM HypogammaglobulinemiaClinical Infectious Diseases, 1996
- CD40 ligand-CD40 interaction in Ig isotype switching in mature and immature human B cellsSeminars in Immunology, 1994